Highly Specific Cytokine Receptor-Targeting Chimeras for Targeted Membrane Protein Degradation and Sensitization of Osimertinib in EGFR-Mutated Non-Small-Cell Lung Cancer

Journal:
Advanced Materials
Published:
DOI:
10.1002/adma.202504050
Affiliations:
3
Authors:
10
Go to article
Institutions Authors Share
Renji Hospital, SJTU, China
4.500000
 0.45
Shanghai Pulmonary Hospital, China
3.000000
 0.30
Hangzhou Institute of Medicine (HIM), CAS, China
2.500000
 0.25
Interested in Pharmacology and Pharmaceutical Sciences?